We are live on ! Find out more
RGNX icon

Regenxbio

167 hedge funds and large institutions have $742M invested in Regenxbio in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 63 increasing their positions, 58 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

121% more call options, than puts

Call options by funds: $4.66M | Put options by funds: $2.11M

5% more capital invested

Capital invested by funds: $705M → $742M (+$36.6M)

9% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 58

0.34% more ownership

Funds ownership: 85.06%85.4% (+0.34%)

4% less funds holding

Funds holding: 174167 (-7)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

Holders
167
Holders Change
-7
Holders Change %
-4.02%
% of All Funds
2.62%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
16
Increased
63
Reduced
58
Closed
23
Calls
$4.66M
Puts
$2.11M
Net Calls
+$2.55M
Net Calls Change
+$1.8M

RGNX Hedge Fund Activity: Q2 2023 in Review

167 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q2 2023, worth a combined $742M — up 5.2% from $705M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of RGNX and 16 opened new positions — a net loss of 7 holders — while 58 trimmed existing stakes and 63 added.

The largest buyer was Sonic GP LLC, adding an estimated $10.6M. The largest seller was Millennium Management, cutting an estimated $9.92M.

  • 167 institutional investors held Regenxbio (RGNX) as of Q2 2023, down from 174 in Q1 2023.
  • Funds reported $742M of Regenxbio stock for Q2 2023, up 5.2% quarter-over-quarter.
  • 16 funds opened new Regenxbio positions in Q2 2023 and 23 closed out, a net change of -7 holders.
  • The largest Regenxbio buyer in Q2 2023 was Sonic GP LLC, an estimated $10.6M added.
  • The largest Regenxbio seller in Q2 2023 was Millennium Management, an estimated $9.92M sold.

Based on aggregated 13F filings for Q2 2023.